Timing of Bicalutamide Administration
Bicalutamide can be taken either in the morning or evening—the choice does not affect efficacy, but it must be taken at the same time each day for consistency. 1
Key Dosing Instructions
According to the FDA-approved prescribing information, the recommended approach is:
- Take one 50 mg tablet once daily (when used in combination with LHRH analog for metastatic prostate cancer)
- Morning OR evening dosing is acceptable—patient preference determines the timing
- Same time every day is required to maintain steady drug levels
- Can be taken with or without food 1
Pharmacokinetic Rationale
The flexibility in timing is based on bicalutamide's unique pharmacokinetic profile:
- The active (R)-enantiomer has an extremely long half-life of approximately 1 week 2
- This results in 10-fold accumulation at steady state during daily administration 2
- The prolonged half-life means that minor variations in daily timing have negligible impact on drug exposure
- Steady-state concentrations are maintained regardless of whether the drug is taken morning or evening
Practical Considerations
Choose the timing that best supports medication adherence:
- If taking multiple morning medications, add bicalutamide to that routine
- If morning regimens are crowded or frequently missed, evening dosing may improve compliance
- The long half-life provides a buffer against occasional timing variations, though consistency remains ideal
Common Pitfalls to Avoid
- Do not take a missed dose late—if a dose is missed, skip it entirely and take the next dose at the regularly scheduled time 1
- Never double dose to make up for a missed dose
- Do not confuse this with short-acting statins, which require evening dosing due to circadian cholesterol synthesis—bicalutamide has no such time-dependent mechanism
The evidence clearly shows that unlike some medications with circadian-dependent mechanisms, bicalutamide's week-long half-life makes timing flexibility possible without compromising therapeutic efficacy.